AIDS-associated mycoplasmas

Annual Review of Microbiology

Volumn 48, Issue , 1994, Pages 687-712

  Blanchard, A ^a   Montagnier, L ^a  

^a INSTITUT PASTEUR   (France)

Author keywords

acquired immunodeficiency syndrome cofactor; human immunodeficiency virus; mollicute; Mycoplasma fermentans; Mycoplasma penetrans; Mycoplasma pirum

Indexed keywords

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ANTIBODY RESPONSE; BACTERIUM ADHERENCE; CELL ADHESION; CELL INVASION; GENETIC VARIABILITY; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MYCOPLASMA; PRIORITY JOURNAL; REVIEW;

BACTERIA (MICROORGANISMS); EUKARYOTA; HUMAN IMMUNODEFICIENCY VIRUS; MYCOPLASMA FERMENTANS; MYCOPLASMA PENETRANS; MYCOPLASMA PIRUM; MYCOPLASMATALES;

EID: 0028061964     PISSN: 00664227     EISSN: None     Source Type: Book Series    
DOI: 10.1146/annurev.mi.48.100194.003351     Document Type: Review

References (144)

1. Almagor M, Kahane I, Gilon C, Yatziv S. 1986. Protective effects of the glutathione redox cycle and vitamin E on cultured fibroblasts infected by Mycoplasma pneumoniae. Infect. Immun. 52:240-44
2. Almagor M, Kahane I, Wiesel JM, Yatziv S. 1985. Human ciliated epithelial cells from nasal polyps as an experimental model for Mycoplasma pneumoniae infection. Infect. Immun. 48:552-55
3. Almagor M, Yatziv S, Kahane I. 1983. Inhibition of host cell catalase by Mycoplasma pneumoniae: a possible mechanism for cell injury. Inject. Immun. 41:251-56
4. Ameisen JC, Capron A. 1991 Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today 12:102-5
5. Amikam D, Glaser G, Razin S. 1984. Mycoplasmas (Mollicutes) have a low number of rRNA genes. J. Bacteriol. 158:376-78
6. Amikam D, Razin S, Glaser G. 1982. Ribosomal RNA genes in mycoplasma. Nucleic Acids Res. 10:4215-22
7. Archibald CP, Schechter MT, Le TN, Craib KJP, Montaner JSG, O'Shaughnessy MV. 1992. Evidence for a sexually transmittted cofactor for AIDS-related Kaposi's sarcoma in a cohort of homosexual men. Epidiomology 3:203-9
8. Asai T, Okada M, Ono M, Irisawa T, Mori Y, et al. 1993. Increased levels of tumor necrosis factor and interleukin 1 in bronchoalveolar lavage fluids from pigs infected with Mycoplasma hyopneumoniae. Vet. Immunol. Immunopathol. 38:263-60
9. Atkin CL, Cole BC, Washburn LR, Wiley BB. 1986. Stimulation of mouse lymphocytes by a mitogen derived from Mycoplasma arthritidis. V. A small basic protein from culture supernatants is a potent T cell mitogen. J. Immunol. 137:1581-89
10. Barile MF, Rottem S. 1993. Mycoplasmas in cell culture. In Rapid Diagnosis of Mycoplasmas, ed. I Kahane, A Adoni, pp. 155-93. New York: Plenum
11. Bauer FA. Wear DJ, Angritt P, Lo SC. 1991. Mycoplasma fermentans (incognitus strain) infection in the kidneys of patients with acquired immunodeficiency syndrome and associated nephropathy: a light microscopic, immunohistochemical, and ultrastructural study. Hum. Pathol. 22:63-69
12. Bebear C. de Barbeyrac B, Clerc M-T, Renaudin H, Fleury HJA, et al. 1993. Mycoplasmas in HIV-1 seropositive patients. Lancet 341:758-59
13. Behbahani N, Blanchard A, Cassell GH, Montagnier L. 1993. Phylogenetic analysis of Mycoplasma penetrans, isolated from HIV-infected patients. FEMS Microbiol. Lett. 109:63-66
14. Beral V, Petermann TA, Berkelman RL, Jaffe HW. 1990. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335:123-28
15. 14a. Bisset LR. 1992 The Mycoplasma genitalium adhesin protein and several human class II MHC proteins exhibit sequence homology: possible ramifications for the development of autoimmunity. Autoimmunity 14:167-68
16. Bhugra B, Dybvig K. 1992. High-frequency rearrangements in the chromosome of Mycoplasma pulmonis correlate with phenotypic switching. Mol. Microbiol. 6:1149-54
17. Blanchard A, Olson LD, Barile MF. 1992. Sexually transmitted mycoplasmas in humans. In Molecular and Cell Biology of Sexually Transmitted Diseases, ed. D Wright, L Archard, pp. 55-83. London: Chapman and Hall
18. Bordier C. 1981. Phase separation of integral membrane proteins in Triton X-114 solution. J. Biol. Chem. 256:1604-7
19. Bové JM. 1993. Molecular features of mollicutes. Clin. Infect. Dis. 17:S10-S31
20. Brenner T, Yamin A, Abramsky O, Gallily R. 1993. Stimulation of tumor necrosis factor-α production by mycoplasmas and inhibition by dexamethasone in cultured astrocytes. Brain Res. 608:273-79
21. Brostoff J. Freedman A, Roitt IM. 1973. Leucocyte migration inhibition to Mycoplasma fermentans in patients with rheumatoid arthritis. Int. Arch. Allergy Appl. Immunol. 45:690-96
22. Buhl R, Holroyd KJ, Mastrangeli A, Cantin AM, Jaffe HA, et al. 1989. Systemic glutathione deficiency in symptom-free HIV-seropositive individuals. Lancet 2:1294-98
23. Buttke TM, Sandstrom PA. 1994. Oxidative stress as a mediator of apoptosis. Immunol. Today 15:7-10
24. Cassell GH, Blanchard A, Waites KB, Duffy L, Crabb D. 1993. Mycoplasmas. In Clinical and Pathogenic Microbiology, ed. BJ Howard, JF Keiser, TF Smith, AS Weisfeld, RC Tilton, et al, pp. 491-502. St Louis, MO: CV Mosby
25. Chirgwin KD, Cummings MC, DeMeo LR, Murphy M, McCormack WM. 1993. Identification of mycoplasmas in urine from persons infected with human immunodeficiency virus. Clin. Infect. Dis. 17:S264-66
26. Chowdhury IH, Munakata T, Koyanagi Y, Kobayshi S, Arai S, Yamamoto N. 1990. Mycoplasma can enhance HIV replication in vitro: a possible cofactor responsible for the progression of AIDS. Biochem. Biophys. Res. Commun. 170:1365-70
27. Cole BC. 1991. The immunobiology of Mycoplasma arthritidis and its superantigen MAM. Curr. Topics Microbiol. Immunol. 174:107-19
28. Cole BC, Atkin CL. 1991. The Mycoplasma arthritidis T-cell mitogen, MAM: a model superantigen. Immunol. Today 12:271-76
29. Cole BC, Washburn LR, Sullivan GJ, Ward JR. 1982. Specificity of a mycoplasma mitogen for lymphocytes from human and various hosts. Infect. Immun. 36:662-66
30. 28a. Dallo SF, Su C-J, Horton JR, Baseman JB. 1988. Identification of P1 gene domain containing epitope(s) mediating Mycoplasma pneumoniae cytoadherence. J. Exp. Med. 167:718-23
31. Dawson MS. Hayes MM, Wang RYH, Armstrong D, Kundsin RB, et al. 1993. Detection and isolation of Mycoplasma fermentans from urine of human immunodeficiency virus type-1-infected patients. Arch. Pathol. Lab. Med. 117:511-14
32. Del Giudice R A, Tully JO, Rose DL, Cole RM. 1985. Mycoplasma pirum sp. nov., a terminal structured mollicute from cell cultures. Int. J. Syst. Bacteriol. 35:285-91
33. De St J, Van der Riet F. 1989. Isolation of "Mycoplasma incognitus." Lancet 336:247
34. Dröge W, Eck H-P, Mihm S. 1992. HIV-induced cysteine deficiency and T-cell dysfunction - a rationale for treatment with N-acetylcysteine. Immunol. Today 13:211-14
35. Dröge W, Eck H-P, Näher H, Pekar U, Daniel V, et al. 1988. Abnormal amino-acid concentrations in the blood of patients with acquired immunodeficiency syndrome (AIDS) may contribute to the immunological defect. Biol. Chem. Hoppe-Seyler 369:143-48
36. Dujardin-Beaumetz E. 1900. Le microbe de la péripneumonie et sa culture. Etude bactériologique d'un microorganisme à la limite de la visibilité. Thèse, Faculté de Médecine de Paris. Octave Doin, Paris
37. Dybvig K. 1990. Mycoplasmal genetics. Annu. Rev. Microbiol. 44:81-104
38. Dybvig K, Alderete J, Watson HL, Cassell GH. 1988. Adsorption of mycoplasma virus P1 to host cells. J. Bacteriol. 170:4373-75
39. Eck H-P, Gmünder H, Hatmann M, Petzoldt D, Daniel V, Dröge W. 1989. Low concentration of acid-soluble thiol (cysteine) in the blood plasma of HIV-1-infected patients. Biol. Chem. Hoppe-Seyler 370:101-8
40. Falkow S, Isberg RR, Portnoy DA. 1992. The interaction of bacteria with mammalian cells. Annu. Rev. Cell Biol. 8:333-63
41. Fauci AS. 1993. Multifactorial nature of human immunodefiency virus disease: implications for therapy. Science 262:1011-18
42. Fenske JD, Kenny GE. 1976. Role of arginine deiminase in growth of Mycoplasma hominis. J. Bacteriol. 126:501-10
43. Gallily R, Salman M, Tarshis M, Rottem S. 1992. Mycoplasma fermentans (incognitus strain) induces TNFα and IL-1 production by human monocytes and murine macrophages. Immunol. Lett. 34:27-30
44. Gougeon ML, Garcia S, Guétard D, Olivier R, Dauguet C, Montagnier L. 1992. Apoptosis as a mechanism of cell death in peripheral lymphocytes from HIV-1 infected individuals. In Immunology of HIV Infection, ed. G Janossy, B Autran, F Miedema, pp. 115-26. Basel: Karger
45. Grau O, Kovacic R, Griffais R, Launay V, Montagnier L. 1994. Development of PCR-based assays for the detection of two human mollicute species, Mycoplasma penetrans and M. hominis. Mol. Cell. Probes. 8:139-48
46. Grau O, Kovacic R, Griffais R, Montagnier L. 1993. Development of a selective and sensitive polymerase chain reaction assay for the detection of Mycoplasma pirum. FEMS Microbiol. Lett. 106:327-34
47. Griffiths MM, Cole BC, Ito J, Harper DC, Anderson CD, et al. 1993. T-cell receptors and collagen induced arthritis in H-2′ mice. Autoimmunity 14:221-29
48. Hawkins RE, Rickman LS, Vermund SH, Carl M. 1992. Association of mycoplasma and human immunodeficiency virus infection: detection of amplified Mycoplasma fermentans DNA in blood. J. Infect. Dis. 165:581-85
49. Hockenbery DM, Oltvai ZN, Yin X-M, Milliman CL, Korsmeyer SJ. 1993. Bcl-2 functions in an antioxidant pathway to prevent apoptosis. Cell 75:241-51
50. Howell MD, Diveley JP, Lundeen KA, Esty A, Winters ST, et al. 1991. Limited T cell receptor B-chain heterogeneity among IL-2R synovial T cells suggests a role for superantigen in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 88:10921-25
51. Hu WS, Wang RY-H, Shih JW-K, Lo S-C. 1993. Identification of a putative infC-rpml-rplT operon flanked by long inverted repeats in Mycoplasma fermentans (incognitus strain). Gene 127:79-85
52. Israël N, Gougerot-Pocidalo M-A, Aillet F, Virelizier J-L. 1994. Influence of redox status of lymphocytes and monocytes on HIV expression and immune functions. Evaluation in vitro of antioxidant molecules as potential anti-HIV therapy. See Ref. 94a, pp. 301-10
53. Janeway C. 1991. Mls: make a little sense. Nature 349:459-61
54. Kaldor JM, Tindall B. Williamson P, Elford J, Cooper DA. 1993. Factors associated with Kaposi's sarcoma in a cohort of homosexual and bisexual men. J. AIDS 6:1145-49
55. Katseni VL, Gilroy CB, Ryait BK, Ariyoshi K, Bieniasz PD, et al. 1993. Mycoplasma fermentans in individuals seropositive and seronegative for HIV-1. Lancet 341:271-73
56. Kingsley LA, Zhou SY, Bacellar H, Rinaldo CR Jr, Chmiel J, et al. 1991. Temporal trends in human immunodeficiency virus type 1 seroconversion 1984-1989. A report from the Multicenter Aids Cohort Study (MACS). Am. J. Epidemiol. 134:331-39
57. Kondo K, Sone H, Yoshida H, Toida T, Kanatani K, et al. 1990. Cloning and sequence analysis of the arginine deiminase gene from Mycoplasma arginini. Mol. Gen. Genet. 221:81-86
58. Krause DC, Baseman JB. 1992. Mycoplasmas which infect humans. See Ref. 74, pp. 417-44
59. Legrand-Poels S, Vaira D, Pincemail J, Van de Vorst A, Piette J. 1990. Activation of human immunodeficiency virus type 1 by oxydative stress. AIDS Res. Hum. Retroviruses 6:1389-97
60. Lemaître L, Guétard D, Hénin Y, Montagnier L, Zerial A. 1990. Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells. Res. Virol. 141:5-16
61. Lemaître M, Hénin Y, Destouesse F, Ferrieux C, Montagnier L, Blanchard A. 1992. Role of mycoplasma infection in the cytopathic effect induced by human immunodeficiency virus type 1 in infected cell lines. Infect. Immun. 60:742-48
62. 59a. Lewis DE, Ulrich RG, Atassi H, Atassi MZ. 1990. HLA-DR peptide inhibits HIV-induced syncitia. Immunol. Lett. 24:127-32
63. Lo S-C. 1986. Isolation and identification of a novel virus from patients with AIDS. Am. J Trop. Med. Hyg. 35:675-76
64. Lo S-C. 1992. Mycoplasmas in AIDS. See Ref. 74, pp. 525-45
65. Lo S-C, Buchholz CL, Wear DJ, Hohm RC, Marty AM. 1991. Histopathology and doxycycline treatment in a previously healthy non-AIDS patient systematically infected with Mycoplasma fermentans (incognitus strain). Mod. Pathol. 6:750-54
66. Lo S-C, Hayes MM, Tully JG, Kotani H, Pierce PF, et al. 1993. Adhesion onto and invasion into mammalian cells by Mycoplasma penetrans: a newly isolated mycoplasma from patients with AIDS. Modern Pathol. 6:276-80
67. Lo S-C, Hayes MM, Tully JG, Wang RY-H, Kotani H, et al. 1992. Mycoplasma penetrans sp. nov., from the urogenital tract of patients with AIDS. Int. J. Syst. Bacteriol. 42:357-64
68. Lo SC, Hayes MM, Wang RYH, Pierce PF, Kotani H, Shih JWK. 1991. Newly discovered mycoplasma isolated from patients infected with HIV. Lancet 338:1415-16
69. Lo S-C, Lange M, Wang R, Klein EB, Inada Y, et al. 1993. Development of Kaposi's sarcoma is associated with serologic evidence of Mycoplasma penetrans infection: retrospective analysis of a prospective cohort study of homosexual men. Natl. Conf. on Human Retroviruses and Related Infections, 1st, Washington, DC. (Abstr.)
70. Lo S-C, Shih JWK, Newton PB III, Wong DM, Hayes MM, et al. 1989. Virus-like infectious agent (VLIA) is a novel pathogenic mycoplasma: Mycoplasma incognitus. Am. J. Trop. Med. Hyg. 41:586-600
71. Lo SC, Tsai S, Benish JR, Shin JW, Wear DJ, Wong DM. 1991. Enhancement of HIV-1 cytocidal effects in CD4+ lymphocytes by the AIDS-associated mycoplasma. Science 251:1074-76
72. Lo S-C, Wang RYH, Newton PB III, Yang NY, Sonoda MA, Shih JWK. 1989. Fatal infection of silvered leaf monkeys with a virus-like infectious agent (VLIA) derived from a patient with AIDS. Am. J. Trop. Med. Hyg. 40:399-409
73. Lo S-C, Wear DJ, Green SL, Jones PG, Legier JF. 1993. Adult respiratory distress syndrome with or without systemic disease associated with infections due to Mycoplasma fermentans. Clin. Infect. Dis. 17:S259-63
74. Lo S-C, Wear DJ, Shih JW-K, Wang RY-H, Newton PB III, Rodriguez JF. 1993. Fatal systemic infections of non-human primates by Mycoplasma fermentans (incognitus strain). Clin. Infect. Dis. 17:S283-88
75. Macon WR, Lo S-C, Poiesz BJ, Montefiori DC, Dawson MS, et al. 1993. Acquired immunodeficiency syndrome-like illness associated with systemic Mycoplasma-fermentans infection in a human immunodeficiency virus-negative homosexual man Hum. Pathol. 24:554-58
76. Maniloff J. 1992. Phylogeny of mycoplasmas. See Ref. 74, pp. 549-59
77. Maniloff J, McElhaney RN, Finch LR, Baseman JB, eds. 1992. Mycoplasmas: Molecular Biology and Pathogenesis. Washington, DC: Am. Soc. Microbiol.
78. Mansel JK, Rosenow EC III, Smith TF, Martin JW. 1989. Mycoplasma pneumoniae pneumonia. Chest 95:639-46
79. Marrack P, Kappler J. 1990. The staphylococcal enterotoxins and their relatives. Science 248:705-11
80. Mastro TD, Satten GA, Nopkesorn T, Sangkharomya S, Longini IM Jr. 1994. Probability of female-to-male transmission of HIV-1 in Thailand. Lancet 343:204-7
81. McGarrity GJ, Vanaman V, Sarama J. 1984. Cytogenetic effects of mycoplasmal infection of cell cultures: a review. In Vitro 20:1-18
82. Meier B, Habermehl GG. 1990. Evidence for superoxide dismutase and catalase in mollicutes and release of reactive oxygen species. Arch. Biochem. Biophys. 277(1):74-79
83. Middleton PJ, Highton TC. 1975. Failure to show mycoplasmas and cytopathogenic virus in rhumatoid arthritis. Ann. Rheum. Dis. 34:369-72
84. Minion FC, Jarvill-Taylor KJ, Billings DE, Tigges E. 1993. Membrane-associated nuclease activities in mycoplasmas. J. Bacteriol. 175:7842-47
85. Mirsalimi SM, Rosendal S, Julian RT. 1989. Colonization of the intestine of turkey embryos exposed to Mycoplasma iowae. Avian Dis. 33:310-15
86. Miyazaki K, Takaku H, Umeda M, Fujita T, Huang W, et al. 1990. Potent growth inhibition of human tumor cells in culture by arginine deiminase purified from a culture medium of Mycoplasma-infected cell line. Cancer Res. 50:4522-27
87. 83a. Montagnier L. 1994. Mycoplasmas as cofactors in AIDS. In New Concepts in AIDS Pathogenesis, ed. L Montagnier, M-L Gougeon, pp. 117-25. Basel, Switzerland: Marcel Dekker
88. 83b. Montagnier L, Berneman D. Guétard D, Blancharc A, Chamaret S, et al. 1990. Inhibition de l'infectiosité de souches prototypes du VIH par des anticorps dirigés contre une séquence peptidique de mycoplasme. C. R. Acad. Sci. 311:425-30
89. Montagnier L, Blanchard A. 1993. Mycoplasmas as co-factors in infection due lo the human immunodeficiency virus. Clin. Infect. Dis. 17:S309-15
90. Montagnier L, Blanchard A, Guétard D. et al. 1991. A possible role of mycoplasmas as co-factors in AIDS. In Retroviruses of Human AIDS and Related Animal Diseases: Proc. Colloque des Cent Gardes, ed. M Girard, L Valette, pp. 9-17. Lyon, France: Fondation M. Merieux
91. Montagnier L, Chermann JC, Barre-Sinoussi F, Chamaret C, Gruest J, et al. 1984. A new human T-lymphocytic retrovirus: characterization and possible role in lymphadenopathy and acquired immune deficiency syndromes. In Human T Cell Leukemia/Lymphoma Viruses, ed. RC Gallo, ME Essex, L Gross, pp. 363-79. Cold Spring Harbor, NY: Cold Spring Harbor Lab.
92. Mühlradt PF, Quentmeier H, Schmitt E. 1991. Involvement of interleukin-1 (IL-1), IL-6, IL-2, and IL-4 in generation of cytolytic T cells from thymocytes stimulated by a Mycoplasma fermentans-derived product. Infect. Immun. 59:3962-68
93. Mühlradt PF, Schade U. 1991. MDHM, a macrophage-stimulatory product of Mycoplasma fermentans, leads to in vitro interleukin-1 (IL-1), IL-6, tumor necrosis factor, and prostaglandin production and is pyrogenic in rabbits. Infect. Immun. 59:3969-74
94. Naot Y. 1982. In vitro studies on the mitogenic activity of mycoplasmal species toward lymphocytes. Rev. Infect. Dis. 4:5205-9
95. Nocard, Roux E. 1898. Le microbe de la péripneumonie. Ann. Inst. Pasteur 12:240-62
96. Nowak J. 1929. Morphologie, nature et cycle évolutif du microbe de la péripneumonie des bovidés. Ann. Inst. Pasteur 43:1330-52
97. Nozaki-Renard J, Iino T, Sato Y, Marumoto Y, Ohta G, Furusawa M. 1990. A fluoroquinolone (DR-3355) protects human lymphocyte cell lines from HIV-1 induced cytotoxicity. AIDS 4:1283-86
98. Olivier R, Lopez O, Mollereau M, Dragic T, Guétard D, Montagnier L. 1994. Prevention of early cell death in peripheral blood lymphocytes of HIV infected individuals by an anti-oxidant: N-acetyl cysteine. See Ref. 94a, pp. 323-32
99. Olson LD, Renshaw CA, Rottem, S, Boal JH. 1993. Arginine utilization by Mycoplasma fermentans is not regulated by glucose metabolism - a C-13-NMR study. FEMS Microbiol. Lett. 108:47-51
100. 94a. Pasquier C, Olivier R, Auclair C, Packer L. eds. 1994. Oxidative Stress, Cell Activation and Viral Infection. Basel, Switzerland: Birkhäuser Verlag
101. Phillips DM, Pearce-Pratt R, Tan X, Zacharopoulos VR. 1992. Association of mycoplasma with HIV-1 and HLTV-I in human T lymphocytes. AIDS Res. Hum. Retroviruses 8:1863-68
102. Plummer FA, Simonsen JN, Cameron DW, Ndinya-Achola JO, Kreiss JK, et al. 1991. Cofactors in male-female sexual transmission of human immunodeficiency virus type 1. J. Infect. Dis. 163:233-39
103. Pollack JD, Hoffmann PJ. 1982. Properties of the nucleases of mollicutes. J. Bacteriol. 152:538-41
104. Pollack JD, Jones MA, Williams MV. 1993. The metabolism of AIDS-associated mycoplasmas. Clin. Infect. Dis. 17:8267-71
105. Quillent C, Gran O, Clavel F, Montagnier L, Blanchard A. 1994. Inhibition of HIV-1 reverse transcriptase assay by nucleases produced by contaminating mycoplasmas. AIDS Res. Hum. Retroviruses. In press
106. Razin S, Jacobs E. 1992. Mycoplasma adhesion. J. Gen. Microbiol. 138:407-22
107. Rink L, Kirchner H. 1992. Mycoplasma arthritidis-derived superantigen. Chem. Immunol. Basel 55:137-45
108. Roederer M, Staal FJT, Osada H, Herzenberg LA, Herzenberg LA. 1991. CD4 and CD8 T cells with high intracellular glutathione levels are selectively lost as the HIV infection progresses. Int. Immunol. 3:933-37
109. 102a. Root-Bernstein RS, Hobbs SH. 1991. Homologies between mycoplasma adhesion peptide, CD4 and class II MHC proteins: a possible mechanism for HIV-mycoplasma synergism in AIDS. Res. Immunol. 142:519-23
110. Ruuth E, Praz F. 1989. Interactions between mycoplasmas and the immune system. Immunol. Rev. 112:133-60
111. Saillard C, Carle P, Bové JM, Bébéar C, Lo SC, et al. 1990. Genetic and serologic relatedness between Mycoplasma fermentans strains and a mycoplasma recently identified in tissues of AIDS and non-AIDS patients. Res. Viral. 141:385-95
112. Sasaki T, Sasaki Y, Kita M, Suzuki K, Watanabe H, Honda M. 1992. Evidence that Lo's mycoplasma (Mycoplasma fermentans incognitus) is not a unique strain among Mycoplasma fermentans strains. J. Clin. Microbiol. 30:2435-40
113. Schreck R, Rieber P, Bauerle PA. 1991. Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-κB transcription factor and HIV-1. EMBO J. 10:2247-58
114. Simecka JW. Davis JK, Davidson MK, Ross SE. Städtlander CTK-H, Cassell GH. 1992. Mycoplasma diseases of animals. See Ref. 74, pp. 391-416
115. Simecka JW, Ross SE, Cassell GH, Davis JK. 1993. Interactions of mycoplasmas with B cells: antibody production and nonspecific effects. Clin. Infect. Dis. 17:5176-82
116. Sonnerborg A, Carlin G, Akerlund B, Pauling L. 1988. Increased production of malondialdehyde in patients with HIV infection. Scand. J. Infect. Dis. 20:287-90
117. Stadtländer CTK-H, Watson HL, Simecka JW, Cassell GH. 1993 Cytopathogenicity of Mycoplasma fermentans (including strain incognitus). Clin. Inject. Dis. 17:5289-5301
118. Sugimura K, Fukuda S, Wada Y, Taniai M, Suzuki M, et al. 1990. Identification and purification of arginine deiminase that originated from Mycoplasma arginini. Infect. Immun. 58:2510-15
119. Sugimura K, Ohno T, Kimura Y, Kimura T, Azuma I. 1992. Arginine deiminase gene of an AIDS-associated mycoplasma, Mycoplasma incognitus. Microbiol. Immunol. 36:667-70
120. Takaku H, Takase M, Abe S-i, Hayashi H, Miyazaki K. 1992. In vitro anti-tumor activity of arginine deiminase purified from Mycoplasma arginini. Int. J. Cancer 51:244-49
121. Taylor-Robinson D, Ainsworth J. 1993. Antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet 341:557-58
122. Taylor-Robinson D, Davies HA, Sarathchandra P, Furr PM. 1991. Intracellular location of mycoplasmas in cultured cells demonstrated by immunocytochemistry and electron microscopy. Int. J. Exp. Pathol 72:705-14
123. Terai C, Kornbluth RS, Pauza CD, Richman DD, Carson DA. 1991. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J. Clin. Invest. 87:1710-15
124. Tham TN, Ferris S, Bahraoui E, Canarelli S, Montagnier L, Blanchard A. 1994 Molecular characterization of the P1-like adhesin gene from Mycoplasma pirum. J. Bacteriol. 176:781-88
125. Tham TN, Ferris S, Kovacic R, Montagnier L, Blanchard A. 1993. Identification of Mycoplasma pirum genes involved in the salvage pathways for nucleosides. J. Bacteriol. 175:5281-85
126. Theiss PM, Kim MF, Wise KS. 1993. Differential protein expression and surface presentation generate high-frequency antigenic variation in Mycoplasma fermentans. Infect. Immun. 61:5123-28
127. Tryon VV, Baseman JB. 1992. Pathogenic determinants and mechanisms. See Ref. 74, pp. 457-71
128. Tully JG, Bové JM, Laigret F, Whitcomb RF. 1993. Revised taxonomy of the class Mollicutes: proposed elevation of a monophyletic cluster of arthropod-associated mollicutes to the ordinal rank (Entomoplasmatales ord. nov.), with provision for familial rank to separate species with nonhelical morphology (Entoplasmataceae fam. nov.) from helical species (Spiroplasmataceae), and emended descriptions of the order Mycoplasmatales, family Mycoplasmataceae. Int. J. Syst. Bacteriol. 43:378-85
129. Vasudevachari MB, Mast TC, Salzman NP. 1990. Suppression of HIV-1 reverse transcriptase activity by mycoplasma contamination of cell cultures. AIDS Res. Hum. Retroviruses 6:411-16
130. Wang RY-H, Hu WS, Dawson MS, Shin JWK, Lo S-C. 1992. Selective detection of Mycoplasma fermentans by polymerase chain reaction and by using a nucleotide sequence within the insertion sequence-like element. J. Clin. Microbiol. 30:245-48
131. Wang RYH, Shih JWK, Grandinetti T, Pierce PF, Hayes MM, et al. 1992. High frequency of antibodies to Mycoplasma penetrans in HIV-infected patients. Lancet 340:1312-16
132. Wang RY-H, Shih JW-K, Weiss SH, Grandinetti T, Pierce PF, et al. 1993. Mycoplasma penetrans infection in male homosexuals with AIDS: high seroprevalence and association with Kaposi's sarcoma. Clin. Infect. Dis. 17:724-29
133. Watson HL, Zheng X, Cassell GH. 1993. Structural variations and phenotypic switching of mycoplasmal antigens. Clin. Infect. Dis. 17:5183-86
134. Weisburg WG, Tully JG, Rose DL, Petel JP, Oyaizu H, et al. 1989. A phylogenetic analysis of the Mycoplasmas: basis for their classification. J. Bacteriol. 171 (12):6455-67
135. Williams MH. 1971. Possible role of Mycoplasma fermentans in the pathogenesis of rheumatoid arthritis. Q. J. Med. 40:577-78
136. Williams MH, Brostoff J, Roitt IM. 1970. Possible role of Mycoplasma fermentans in pathogenesis of rheumatoid arthritis. Lancet 2:277-80
137. Williams MH, Bruckner FE. 1971. Immunological reactivity to Mycoplasma fermentans in patients with rheumatoid arthritis. Preliminary communication. Ann. Rheum. Dis. 30:271-3
138. Windsor GD, Nichols A, Maini RN, Edward DGH, Lemcke RM, Dumonde DC. 1974. Search for mycoplasma in synovial fluids from patients with rhumatoid arthritis. Ann. Rheum. Dis. 33:70-74
139. Wise KS. 1993. Adaptive surface variation in mycoplasmas. Trends Microbiol. 1:59-63
140. Wise KS, Kim MF. 1987. Major membrane surface proteins of Mycoplasma hyopneumoniae selectively modified by covalently bound lipid. J. Bacteriol. 169:5546-55
141. Woese CR. 1987. Bacterial evolution. Microbiol. Rev. 51:221-71
142. Woese CR, Maniloff J, Zablen LB. 1980. Phylogenetic analysis of the mycoplasmas. Proc. Natl. Acad. Sci. USA 77:494-98
143. Yogev D, Rosengarten R, Watson-McKown R, Wise K. 1991. Molecular basis of Mycoplasma surface antigenic variation: a novel set of divergent genes undergo spontaneous mutation of periodic coding regions and 5′ regulatory sequences. EMBO J. 10:4069-79
144. Dadaglio G, Garcia S, Montagnier L, Gougeon M-L. 1994. Selective anergy of Vβ8+ T cells in human immunodeficiency virus-infected individuals. J. Exp. Med. 179:413-24